INTRODUCTION {#S2}
============

An accurate understanding of gene regulation requires identification of DNA control elements that function as transcriptional enhancers *in vivo* ([@R23]). A common technique in enhancer identification is the production of transgenic reporter animals that carry putative DNA control elements joined to reporter genes that are randomly inserted in the genome ([@R4]; [@R6]). Here, we examined putative enhancers for *Tbx5*, a gene mutated in some humans suffering from forelimb and heart developmental defects ([@R5]).

During forelimb development, mouse *Tbx5* and its zebrafish homolog *tbx5a* are both expressed in the early forelimb field, where they are required for initiation of forelimb outgrowth, i.e., arms in mouse and pectoral fins in zebrafish; genetic loss-of-function results in complete absence of forelimbs or pectoral fins ([@R3]; [@R2]; [@R19]). Transgenic mouse studies identified a DNA element lying within intron 2 of mouse *Tbx5* that conferred transgene expression specifically in the forelimb field ([@R15]). A minimal element needed for transgene expression was reported to contain six HOX-binding sites in a 361-bp region, with four additional HOX-binding sites located close upstream ([Figure 1](#F1){ref-type="fig"}), supporting the hypothesis that *Hox4* and *Hox5* genes known to be expressed in the forelimb field may function to activate *Tbx5* in this location ([@R15]; [@R16]). Further studies on the minimal 361-bp DNA element reported that it also contains a T*cf*/Lef (Wnt/β-catenin) binding site and a retinoic acid response element (RARE) ([@R17]). The report of a T*cf*/Lef (Wnt/β-catenin) binding site was supported by β-catenin conditional knockout studies showing partial loss of forelimb *Tbx5* expression ([@R17]). However, the suggestion that a RARE may be required for forelimb *Tbx5* activation ([@R17]) is in contradiction to mouse and zebrafish RA genetic loss-of-function studies showing that RA is not directly required to activate *Tbx5* in the forelimb field but that RA is required to repress *Fgf8* in the forelimb field in order to permit forelimb *Tbx5* activation by an unknown activator ([@R8]).

Whereas the intron 2 *Tbx5* enhancer is conserved only in mammals ([@R15]), transgenic reporter studies in zebrafish described a *tbx5a* forelimb (pectoral fin) enhancer (cns12sh) located downstream that is conserved from fish to mammals ([@R1]). Transgenic zebrafish carrying either the zebrafish cns12sh sequence or the conserved mouse cns12sh sequence were able to drive gene expression in the zebrafish pectoral fin field, demonstrating conservation of cns12sh activity in the forelimb ([@R1]). The *Tbx5* cns12sh enhancer was not analyzed to identify any potential DNA-binding transcription factors, and its sequence is not similar to the *Tbx5* intron 2 enhancer.

Further studies were performed here to determine whether either of these elements is required for activation of the endogenous *Tbx5* or *tbx5a* genes in the forelimb fields of mouse or zebrafish, respectively.

RESULTS {#S3}
=======

In order to further examine the potential functions of the intron 2 and cns12sh *Tbx5* forelimb enhancers, including a putative RARE, we first performed CRISPR/Cas9 gene editing to delete the endogenous elements in mouse ([Figure 1](#F1){ref-type="fig"}). With regard to the *Tbx5* forelimb enhancer reported to reside inside intron 2, we obtained one deletion mutant that removed 357 bp, including most of the conserved 361-bp element, and another deletion mutant that removed 548 bp, including the entire conserved 361-bp element plus the four additional upstream HOX-binding regions ([Figure S1](#SD1){ref-type="supplementary-material"}). Mouse lines homozygous for each deletion produced offspring that were healthy and reproductive. For each homozygous deletion, E9.5 embryos exhibited normal expression of *Tbx5* in the forelimb field and normally sized forelimb buds (357-bp deletion, n = 12; 548-bp deletion, n = 10) ([Figures 2A and 2B](#F2){ref-type="fig"}). Examination of embryos at embryonic day 14.5 (E14.5) showed that both homozygous deletion mutants exhibited normal forelimb skeleton formation (357-bp deletion, n = 7; 548-bp deletion, n = 10) ([Figure 2C](#F2){ref-type="fig"}). Thus, loss of the *Tbx5* intron 2 DNA element had no effect on forelimb *Tbx5* expression, forelimb initiation, or fore-limb development. Our results suggest that the HOX-binding sites, RARE, and T*cf*/Lef Wnt/β-catenin elements that reside in the intron 2 element are not required for forelimb *Tbx5* activation.

As our studies show that the mouse *Tbx5* intron 2 DNA element is not required for forelimb development, another DNA element must be required. The *Tbx5* intron 2 DNA element is conserved only in mammals ([@R15]); however, other studies performed in zebrafish discovered a \~200-bp DNA element called cns12sh located \~30 kb downstream of *tbx5a* that confers forelimb-specific expression using zebrafish transgenic enhancer analysis; sequence alignment showed cns12sh is conserved from jawed fishes to mammals, including humans ([@R1]). No evidence was presented for putative transcriptional regulatory proteins that may bind the cns12sh element. In mouse, the cns12sh element is located \~100 kb downstream of *Tbx5* in a 200-bp region ([Figure 1](#F1){ref-type="fig"}). Using CRISPR/Cas9 gene editing, we generated a mouse line carrying a homozygous 779-bp deletion, including the conserved cns12sh element ([Figures 1](#F1){ref-type="fig"} and [S2](#SD1){ref-type="supplementary-material"}). Mice carrying the 779-bp deletion were used to generate homozygous deletion embryos (cns12 KO), which exhibited normal forelimb expression of *Tbx5* and normal forelimb initiation at E9.5 (n = 10), plus normal forelimb skeleton formation at E14.5 (n = 4), similar to the intron 2 element homozygous deletion (in2 KO) ([Figures 3A and 3B](#F3){ref-type="fig"}). Thus, like the intron 2 element, the cns12sh element is not required for mouse forelimb development.

In order to determine whether the *Tbx5* intron 2 and downstream cns12sh elements may function redundantly, we generated double mutants. As these elements are located relatively close together on the same chromosome, we used an iterative approach. Fertilized oocytes derived from animals carrying the 548-bp deletion within intron 2 were used for a second round of CRISPR/Cas9 gene editing for the cns12sh element, which resulted in generation of a 772-bp deletion, including cns12sh, very similar to the location of the 779-bp deletion in the single mutant ([Figures 1](#F1){ref-type="fig"} and [S2](#SD1){ref-type="supplementary-material"}). Surprisingly, embryos carrying homozygous deletions of both the intron 2 and cns12sh elements (double knockout \[dKO\]) exhibited normal forelimb expression of *Tbx5* and normal forelimb initiation at E9.5 (n = 7), as well as normal forelimb skeleton formation at E14.5 (n = 5) ([Figures 3A and 3B](#F3){ref-type="fig"}). A comparison of forelimb *Tbx5* expression and skeletal element lengths in the single and double knockouts shows no significant difference with wild-type ([Figure 3C](#F3){ref-type="fig"}). These results demonstrate that the intron 2 and cns12sh elements do not exhibit a redundant function with each other that is required for activation of *Tbx5* expression in the mouse forelimb.

As the cns12sh element was originally reported to be a fore-limb *tbx5a* enhancer in transgenic zebrafish ([@R1]), we wondered whether this element may have a function in initiation of zebrafish pectoral fin outgrowth that was lost during later evolution of mammals. We generated a line of zebrafish carrying a 248-bp deletion, including the conserved cns12sh element ([Figures 4A](#F4){ref-type="fig"} and [S3](#SD1){ref-type="supplementary-material"}). From matings of heterozygous deletion mutant parents, we obtained zebrafish offspring homozygous for the 248-bp cns12sh deletion that all exhibited normal pectoral fins; (first mating offspring: wild-type \[WT\] n = 4, +/− n = 18, −/− n = 6; second mating offspring: WT n = 7, +/− n = 11, −/− n = 6) ([Figure 4B](#F4){ref-type="fig"}). A comparison of pectoral fin length shows no significant difference between the cns12sh knockout and wild-type ([Figure 4C](#F4){ref-type="fig"}). These findings demonstrate that the cns12sh element is not required for initiation of zebrafish pectoral fin outgrowth.

DISCUSSION {#S4}
==========

For more than 30 years, numerous transgenic animal studies have been used to provide *in vivo* evidence for DNA elements that function as transcriptional enhancers. Identification of presumed enhancers in transgenic animals is considered highly superior to analysis of enhancers in cell lines; however, this technique involves ligation of a DNA element to a reporter gene and random insertion in the genome far from its normal location. With the CRISPR/Cas9 single and double knockout studies presented here, we show that one cannot rely only on reporter transgenes to identify enhancers that are biologically necessary. Our findings suggest that DNA regulatory elements that are closely linked to a basal promoter and randomly inserted into the genome may exhibit enhancer functions that do not exist in their normal location, often far from the nearest promoter. Thus, although reporter transgenes can identify potential enhancers, identification of a true enhancer that is necessary for gene regulation requires the observation of a defect after knocking out the endogenous DNA element in its normal location or knocking it out along with one or more additional DNA elements in the case of enhancer redundancy.

Here, we were unable to build upon four previously published transgene studies on two presumed *Tbx5* enhancers independently identified in two vertebrate animals ([@R15]; [@R16], [@R17]; [@R1]). Instead, our findings indicate that at least one other unknown DNA element must be required for activation of forelimb *Tbx5* in both mouse and zebrafish. In addition, our mouse double knockout studies show that the intron 2 and cns12sh elements do not share redundant or additive functions for forelimb development with each other, i.e., not even a partial effect on *Tbx5* expression that is enough to effect forelimb development in the double knockout; in contrast, the *Tbx5* knockout results in complete loss of forelimbs ([@R3]; [@R2]; [@R19]). It may be possible that one or both of these DNA elements share a redundant function with an unknown third DNA element. However, recent enhancer knockout studies by others demonstrated that, when two or more endogenous DNA elements exhibit redundancy for gene activation *in vivo*, they typically function additively instead of completely redundantly ([@R24]; [@R6]; [@R9]; [@R18]). Thus, as we see no effect on *Tbx5* expression when both of the *Tbx5* DNA elements are deleted, it is possible that neither of these DNA elements are required for activation of *Tbx5* or initial forelimb outgrowth, i.e., they may not share a redundant function with an unknown third DNA element that is yet to be discovered. We suggest that, even though the intron 2 and cns12sh elements can activate transcription when placed near basal promoters in ectopic genomic locations, in their normal genomic locations they may not be properly positioned within their topologically associated domain (TAD) to control forelimb *Tbx5* activation. Thus, the *Tbx5* DNA elements we examined may be vestigial enhancers or pseudoenhancers, i.e., enhancers that once had a required function in forelimb activation that has been lost during evolution. Further knockout studies on another potential forelimb *Tbx5* enhancer are needed to resolve this issue. Additional enhancer candidates may be obtained by analyzing the *Tbx5* genomic landscape during forelimb initiation using chromatin conformation capture and other chromatin profiling techniques. One such study that included an analysis of H3K27ac marks near mouse *Tbx5* estimated it may be regulated by at least four enhancers in developing limbs at E11.5 ([@R18]); we observed that the intron 2 enhancer is included within a very large region marked by H3K27ac, whereas the cns12sh enhancer is not marked by H3K27ac; however, analysis at E11.5 may be too late to make conclusions on potential enhancers, as *Tbx5* is activated at E8.5 in mouse ([@R2]).

Our observations indicate that enhancer reporter transgene findings need to be validated by enhancer knockout studies before concluding that factors binding the enhancer are required for gene regulation. Importantly, as the RARE reported to exist in the mouse *Tbx5* intron 2 enhancer ([@R17]) was deleted in our studies without any effect on forelimb *Tbx5* expression, the RARE enhancer data can no longer be used to support a role for RA receptors and RA in activation of *Tbx5* in the forelimb. Our observation of no effect on forelimb *Tbx5* expression following loss of the RARE is consistent with previous studies demonstrating that RA is not directly required for *Tbx5* activation in zebrafish or mouse but instead that RA is required for repression of *Fgf8* to permit activation of *Tbx5* by some other mechanism in both zebrafish and mouse ([@R8]). Our knockout studies also demonstrate that the Hox binding and T*cf*/Lef (Wnt/β-catenin) binding sites previously reported in the *Tbx5* intron 2 DNA element ([@R15]; [@R16], [@R17]) are not required for *Tbx5* forelimb activation.

Several RAREs have been previously studied *in vivo* using reporter transgenes, but only a few have been subjected to genetic loss of function to determine whether they are required for regulation of a nearby gene ([@R7]). Traditional knockout studies using embryonic stem cells identified RAREs that are required to activate *Cdx1* ([@R12]) and *Hoxa1* ([@R10]). Recent CRISPR/Cas9 gene editing was used to identify a silencer RARE that is required for RA repression of *Fgf8* ([@R14]). In the future, we recommend that *in vivo* knockout analyses be performed before concluding that a DNA element is required as a RARE.

Our double knockout studies provide a compelling case for moving to reliance on genetic disruption of endogenous noncoding DNA elements to provide a definitive answer on whether a DNA element is required for gene regulation. Reporter transgenes can identify candidate enhancers, but verification of function by knockout is necessary to move the field forward in a positive direction. A CRISPR/Cas9 knockout approach requires about the same time, effort, and cost compared to the traditional strategy of generating mice or zebrafish carrying transgenic reporters, and CRISPR facilitates the ability to generate double knockouts in the case of redundancy. Validation of enhancers or silencers with *in vivo* knockout studies will allow the field of epigenetics to focus on changes observed in DNA elements that are necessary for gene regulation *in vivo*.

EXPERIMENTAL PROCEDURES {#S5}
=======================

Animal Studies {#S6}
--------------

All mouse and zebrafish studies conformed to the regulatory standards adopted by the Institutional Animal Care and Use Committee at the SBP Medical Discovery Institute, which approved this study under Animal Welfare Assurance Number A3053-01. Age and gender were not relevant for this study, as analysis was performed on embryos.

Generation of Mutant Mice {#S7}
-------------------------

CRISPR/Cas9 gene editing was performed as previously described ([@R14]), using two single-guide RNA (sgRNAs) flanking either the mouse *Tbx5* intron 2 DNA element or the downstream cns12sh DNA element in order to delete these elements (see [Figures S1 and S2](#SD1){ref-type="supplementary-material"}). Fertilized mouse oocytes injected with Cas9mRNA and sgRNAs targetingeither the *Tbx5*intron 2 DNA element ([@R15]) or the *Tbx5* cns12 downstream element ([@R1]) were allowed to proceed to birth to generate mouse lines. In order to generate double mutants carrying deletions of both the *Tbx5* intron 2 element and the cns12 downstream element, a mouse line homozygous for the intron 2 DNA element deletion was used to prepare fertilized oocytes that were then injected with sgRNAs for the cns12 downstream element deletion. Mutant F0 adult mice were identified by DNA sequencing of PCR products overlapping the mutation from analysis of tail DNA. Further matings to wild-type mice generated F1 heterozygous mutants, and F1 matings generated F2 homozygous deletion mutants. Embryos at stages E9.5 and E14.5 were generated from timed matings of mice carrying heterozygous or homozygous deletion alleles; embryos were genotyped by PCR analysis of yolk sac DNA.

Generation of Mutant Zebrafish {#S8}
------------------------------

CRISPR/Cas9 gene editing was performed in zebrafish as previously described ([@R11]; [@R13]), using EnGen Cas9 NLS protein from *S. pyogenes* (New England Biolabs) and two sgRNAs flanking the *tbx5a* cns12sh conserved DNA element (see [Figure S3](#SD1){ref-type="supplementary-material"}). Adult F0 fish were genotyped using PCR analysis and DNA sequencing of tail clips, and further matings of positive F0 fish generated F1 heterozygotes and F2 homozygotes. Embryos (5 days old) were imaged and genotyped by PCR analysis of genomic DNA isolated from whole embryos.

PCR Primers for Genotyping of Mice and Zebrafish {#S9}
------------------------------------------------

Genotyping of mice carrying a deletion of the *Tbx5* intron 2 enhancer:

1.  Tbx5-in2-Fwd 5′-TTCAGCTTGGAGTGAAGGGT-3′

2.  Tbx5-in2-Rev 5′-TCAGTGATGGGTCTTAGCGG-3′

Genotyping of mice carrying a deletion of the *Tbx5* cns12sh enhancer:

1.  Tbx5-cns12sh-Fwd 5′-GTCCTCGGCACTACATACGA-3′

2.  Tbx5-cns12sh-WT-Rev 5′-CCCGGGGTCATCTGTTTTCA-3′ (to detect wild-type)

3.  Tbx5-cns12sh-mut-Rev 5′-TGTAGCCTTGGTTGGTCTGA-3′ (to detect mutant).

Genotyping of zebrafish carrying a deletion of the *Tbx5* intron 2 enhancer:

1.  ztbx5a-cns12sh-Fwd 5′-GCTCAGACAAATTCCAAGCGT-3′

2.  ztbx5a-cns12sh-Rev 5′-TGTGAACAAAGTTTTCGGTTGA-3′

Detection of mRNA and Limb Skeletal Elements {#S10}
--------------------------------------------

Detection of *Tbx5* and *Uncx* mRNAs was performed by whole-mount *in situ* hybridization as previously described ([@R22]). ImageJ software (<https://imagej.net/welcome>; [@R21]) was used to quantitate forelimb *Tbx5* mRNA in photographs of E9.5 mouse embryos that were stage matched (embryos with 24 or 25 somites detected by *Uncx* expression), stained the same day for an equal length of time, and photographed at the same magnification; briefly, the ImageJ area selection tool was used to select regions of equal size in the forelimb domains of each embryo and then average pixel density was measured. Alcian blue and Alizarin red staining of cartilage and bone was performed as previously described ([@R20]) to enable quantification of forelimb skeletal element length in E14.5 mouse embryos; skeletal element lengths were measured in photographs of forelimbs taken at the same magnification for all genotypes.

Statistical Analysis {#S11}
--------------------

Statistical analysis was performed using one-way ANOVA (non-parametric test) to compare across all genotypes with data presented as mean ± SD and with p \> 0.05 indicating non-significance.

Supplementary Material {#S13}
======================

We thank the Animal Resources Core Facility at SBP Medical Discovery Institute for conducting timed matings to generate mouse embryos and Judy Wade for help generating fertilized mouse oocytes from *Tbx5* intron 2 (Δ548) mutants to use for iterative CRISPR/Cas9 editing to also introduce the cns12sh mutation to produce double mutants. This work was funded by NIH grant R01 AR067731 (to G.D.).
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![Strategy for Knockout of Putative Mouse Forelimb *Tbx5* Enhancer\
CRISPR/Cas9 gene editing was used to delete the *Tbx5* intron 2 DNA element ([@R15]) and the downstream cns12sh element ([@R1]) using two sgRNAs flanking each element. Yellow and green bars within the intron 2 element designate reported HOX-binding sites within and upstream of the minimal 361-bp sequence ([@R15]; [@R16]). Additional reported control elements include a RARE (R) and a T*cf*/Lef Wnt/β-catenin control element (W) ([@R17]). See also [Figures S1 and S2](#SD1){ref-type="supplementary-material"}.](nihms978727f1){#F1}

![Analysis of Mice Carrying Deletions of the *Tbx5* Intron 2 DNA Element\
(A and B) Expression of *Tbx5* in E9.5 wild-type (+/+) embryos compared to embryos carrying either a 357-bp deletion (Δ357) (A) or a 548-bp deletion (Δ548) (B) that eliminates the putative *Tbx5* fore-limb enhancer within intron 2; scale bar: 0.3 mm (same for all panels).\
(C) Skeletal staining of E14.5 deletion mutants compared to wild-type; scale bar: 1 mm (same for all panels). See [Figure 3](#F3){ref-type="fig"} for quantification.](nihms978727f2){#F2}

![Analysis of Mice Carrying Deletions of the *Tbx5* cns12sh Element or Both Intron 2 and cns12sh Elements\
(A) Expression of both *Tbx5* and *Uncx* (somites) in E9.5 embryos carrying homozygous deletions of putative *Tbx5* forelimb enhancers; cns12 KO, cns12 element 779-bp deletion; dKO, double KO containing intron 2 element 548-bp deletion and cns12 element 772-bp deletion; in2 KO, intron 2 element 548-bp deletion; WT, wild-type; scale bar: 0.3 mm (same for all panels).\
(B) Skeletal staining of E14.5 homozygous deletion mutants compared to WT; scale bar: 1 mm (same for all panels).\
(C) Comparison of forelimb *Tbx5* expression in stage-matched E9.5 embryos (24 or 25 somites detected by *Uncx* expression) and forelimb skeletal element lengths (humerus, radius, and ulna) at E14.5 across the indicated genotypes; data are expressed as mean ± SD. For all comparisons, p \> 0.05 (not significant difference) using one-way ANOVA non-parametric test (n = 3 biological replicates for each genotype, stage-matched).](nihms978727f3){#F3}

![Deletion of Zebrafish *tbx5a* cns12sh DNA Element\
(A) CRISPR/Cas9 gene editing strategy to delete the zebrafish*tbx5a* cns12shelement ([@R1]). (B) Zebrafish 5-day-old embryos showing pectoral fins (arrows) in wild-type as well as heterozygous and homozygous cns12sh deletion mutants; scale bar: 1 mm (same for all panels).\
(C) Comparison of pectoral fin lengths; data are expressed as mean ± SD. For all comparisons, p \> 0.05 (not significant difference) using one-way ANOVA non-parametric test (n = 4 biological replicates for each genotype, stage-matched).\
See also [Figure S3](#SD1){ref-type="supplementary-material"}.](nihms978727f4){#F4}

###### Highlights

-   Putative *Tbx5* forelimb enhancers were deleted in mouse and zebrafish using CRISPR/Cas9

-   Double knockouts of the two enhancers show both are nonessential and nonredundant

-   A retinoic acid response element in one enhancer is nonessential for forelimb growth

-   Knockout studies are needed to infer necessity of proposed transcriptional enhancers
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